Brief: Vanta Bioscience Says Unit Signs Agreement Of 290 Mln Rupees With Emcure Pharmaceuticals
05/04/2019 12:16
April 5 (Reuters) - Vanta Bioscience Ltd VANB.BO :
* SAYS UNIT SIGNS CRO SERVICE AGREEMENT OF 290 MILLION
RUPEES WITH
EMCURE PHARMACEUTICALS LIMITED
Source text for Eikon: ID:nBSEbktZ1h
Further company coverage: VANB.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vanta Bioscience
See all newsWellington-led funding boosts Vanta's valuation by 69% in a year (updated)
Advisory: Alert incorrectly tagged to Vanta Bioscience withdrawn
Brief: Vanta Expands Australia & New Zealand Presence With New Data Centre & Support For Additional Compliance Framework
Sequoia Capital-backed Vanta raises funding at $2.45 bln valuation (updated)
Brief: Vanta Bioscience Gets Order Worth 5.7 Million Rupees For GLP Studies